Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon, MultiD Reach Software Deal

Bya GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exiqon and MultiD Analyses today announced a development and distribution agreement incorporating a specifically adapted version of MultiD's GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform.

As a result of the deal, Exiqon will now be able to sell a fully compatible and comprehensive data analysis solution to complete its microRNA qPCR offering, the company said in a statement.

GenEx software is used to process and analyze qPCR data, and its capabilities include the selection and validation of reference genes, data pre-processing, and advanced statistical methods for the analysis of qPCR experiments.

The newly designed software for Exiqon's new qPCR platform — called the miRCURY LNA Universal RT microRNA PCR system — includes a plate design module which enables customers to design their qPCR experiments in silico and "generate templates for import into their real-time PCR instrument," Mikael Kubista, chairman of MultiD, said in a statement.

Based in Vedbaek, Denmark, Exiqon develops tools for microRNA research. MultiD is headquartered in Göteborg, Sweden, and develops software for qPCR analysis.

Financial terms of the agreement were not disclosed.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.